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Abstract. Beginning during the second half of gesta- 
tion, increasing numbers of cardiac myocytes withdraw 
from the cell cycle such that DNA synthesis is no longer 
detectable in these cells by neonatal day 17 in vivo. The 
mechanisms that exclude these and other terminally 
differentiated cells from the cell division cycle are 
poorly understood. To begin to explore the molecular 
basis of the barrier to G1/S progression in cardiac myo- 
cytes, we used adenoviruses to express wild-type and 
mutant E1A proteins in primary cultures from embry- 
onic day 20 rats. While most of these cardiac myocytes 
are ordinarily refractory to DNA synthesis, even in the 
presence of  serum growth factors, expression of wild-type 
E1A stimulates DNA synthesis in up to 94% or almost 
all successfully transduced cells. Rather than complete 
the cell cycle, however, these cells undergo apoptosis. 
Apoptosis is limited to those cells that engage in DNA 
synthesis, and the kinetics of the two processes suggest 
that DNA synthesis precedes apoptopsis. Mutations in 
E1A that disable it from binding Rb and related pocket 
proteins have little effect on its ability to stimulate 
DNA synthesis in cardiac myocytes. In contrast, mu- 
tants that are defective in binding the cellular protein 
p300 stimulate DNA synthesis 2.4-4.1-fold less effi- 
ciently, even in the context of retained E1A pocket 
protein binding. In the absence of EIA pocket protein 
binding, the usual situation in the cell, loss of p300 
binding severely decreases the ability of E1A to stimu- 
late DNA synthesis. These results suggest that the bar- 
rier to G1/S progression in cardiac myocytes is medi- 
ated, at least in part, by the same molecules that gate 
the G1/S transition in actively cycling cells, and that 
p300 or related family members play an important role 
in this process. 
M 
OST  adult mammalian cells exist  in a quiescent 
state (GO), characterized by the absence  of net 
DNA  synthesis  and cell  division.  While some 
GO ceils retain the ability to resume proliferative growth in 
response  to certain signals,  others that have undergone 
terminal differentiation are  permanently excluded from 
the cell cycle. The mechanisms  that prevent cell cycle re- 
entry in terminally differentiated  cells are unclear. Striated 
muscle cells, including skeletal and cardiac myocytes, ex- 
emplify the  terminally  differentiated state.  In  skeletal 
muscle,  terminal  differentiation involves  three  distinct 
processes:  commitment, in which proliferating myoblasts 
withdraw irreversibly  from the cell cycle; fusion of com- 
mited myoblasts into multinucleated myocytes; and induc- 
tion of muscle specific genes (Nguyen et al., 1983). MyoD, 
myogenin, myf-5, and MRF 4 comprise a family of skeletal 
myogenic determination factors (MDFs),  1  whose members 
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are sufficient to accomplish all three of these steps, as evi- 
denced by their ability to convert a variety of nonmuscle 
cells to skeletal myocytes (reviewed  in Weintraub, 1993). 
MDFs are basic helix-loop-helix transcription factors that 
transactivate the  expression  of multiple muscle-specific 
genes. In addition, these proteins exhibit intrinsic growth 
suppressive properties in both myogenic and nonmyogenic 
cells (Sorrentino et al., 1990; Crescenzi et al., 1990). MDF- 
induced growth inhibition requires member(s) of the ret- 
inoblastoma (Rb)  family of pocket proteins  (Gu et al., 
1993), which also include p107 and p130. Although MDFs 
bind directly to pocket proteins in vivo (Gu et al., 1993; 
Schneider et al., 1994), the precise  mechanism by which 
they suppress  growth remains unclear,  and recent work 
suggests that these effects may be indirect (Halevy et al., 
1995; Skapek et al., 1995; Parker et al., 1995). 
While both skeletal and cardiac myocytes~are  special- 
ized contractile cells, they differ fundamentally from a de- 
velopmental perspective.  Skeletal  myoblasts .~rise from 
the somites around midgestation (Holtzer et al., 1957); in 
contrast, cardiac myoblasts originate earlier and from the 
lateral plate mesoderm (Rawles,  1943; reviewed in Litvin 
et al., 1992). Furthermore, in contrast to skeletal myogene- 
sis, where cell cycle withdrawal precedes fusion and the 
expression  of muscle-specific genes (Nadal-Ginard, 1978), 
fully functioning cardiac myocytes develop from their pre- 
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(Goldstein et al., 1974). As ontogeny progresses, however, 
an  increasing proportion  of cardiac myocytes withdraw 
from the cell cycle so that, by neonatal days 15-17, DNA 
synthesis is  not  detectable  in  cardiac  myocytes in  vivo 
(Claycomb,  1975; Rumyantsev, 1977; Kim et  al.,  1994). 
Forced expression of c-myc (Jackson et al., 1990) and SV-40 
T antigen (Field, 1988; Behringer et al., 1988; Katz et al., 
1992) in transgenic hearts beginning early in fetal life can 
induce cardiac myocyte hyperplasia and/or tumorigenesis; 
however, these genetic perturbations by themselves are in- 
sufficient to allow the direct establishment of permanent 
lines of differentiated cardiac myocytes (Jackson  et al., 
1990; Steinhelper et al., 1990). The molecules, which induce 
and maintain terminally differentiation in cardiac myocytes, 
have not been identified; specifically, the skeletal MDFs 
are absent (reviewed in Olson, 1993). 
To begin to understand the molecular basis of terminal 
differentiation in cardiac myocytes, we have exploited two 
properties of adenoviruses. First, these viruses are able to 
infect primary cultures of cardiac myocytes with high effi- 
ciency (Kirshenbaum et al., 1993; Kass-Eisler et al., 1993). 
Second,  adenoviruses express  an endogenous oncogene, 
E1A, which facilitates G1  to S progression in nontermi- 
nally differentiated cells (Howe et al.,  1990)  and whose 
structure-function  relationships  have  been  particularly 
well delineated (reviewed in Bayley and Mymryk, 1994). 
We reasoned that if E1A were able to surmount the G1/S 
block in cardiac myocytes, it might be possible to explore 
the molecular nature of this barrier by assaying the ability 
of various E1A  mutants to stimulate DNA  synthesis in 
cardiac myocytes. Although the products of the EI~ .... 
stimulate DNA synthesis in nonterminally differentiated 
cells, their ability to transform these cells is quite limited 
because  they also induce apoptosis  or programmed cell 
death through a p53-dependent mechanism (Debbas and 
White, 1993; Lowe and Ruley, 1993). E1A-induced apop- 
tosis can be inhibited by the products of the adenovirus 
E1B gene and the cellular bcl-2 gene (Rao et al., 1992; re- 
viewed in White, 1993). Both the ability of E1A to induce 
cellular DNA synthesis and apoptosis map to residues at 
the  extreme  amino  terminus  and  in  conserved  regions 
(CR) 1 (amino acids 40-80) and 2 (amino acids 120-138). 
These E1A functions are thought to be mediated through 
its interactions with several host proteins. These include 
p300, a transcriptional adaptor molecule (reviewed in Mo- 
ran, 1993; Eckner, et al., 1994), which requires residues at 
the extreme amino terminus of E1A and the carboxy end 
of CR1 for full binding, as well as pocket proteins whose 
binding maps to residues in CR2 and the amino portion of 
CR1 (Wang et al., 1993). E1A mutants defective for p300 
binding alone are modestly impaired in their abilities to 
stimulate  cellular DNA  synthesis in  cycling cells  while 
those unable to bind pocket proteins alone perform this 
function normally. Mutants defective for binding both of 
these classes of proteins, however, are completely crippled 
in this regard (Howe et al.,  1990). Expression of E1A in 
skeletal myoblasts inhibits the  activation of muscle-spe- 
cific genes and differentiation of these cells (Webster et 
al., 1988; Enkemann et al., 1990; Braun et al., 1992; Mym- 
ryk et al., 1992; Caruso et al., 1993; Taylor et al.,  1993). 
The effect of E1A expression in striated muscle cells that 
have  already undergone  terminal  differentiation is  not 
known, however. 
In this study, we demonstrate that expression of E1A is 
sufficient to stimulate DNA synthesis in embryonic day 20 
cardiac myocytes, most of which are ordinarily refractory 
to this process,  even in serum-containing media. Rather 
than undergoing mitosis, however, these  same  cells  un- 
dergo  apoptosis.  Finally, mutations disabling E1A  from 
binding p300--both in the presence and absence of pocket 
protein binding--decrease the ability of this oncoprotein 
to stimulate DNA synthesis in these cells.  These results 
suggest that p300 and/or related family members contrib- 
ute to the regulation of DNA synthesis in cardiac myo- 
cytes. 
Materials and Methods 
Primary Rat Cardiac Myocyte Cultures 
Cultures of cardiac myocytes were prepared from the hearts of embryonic 
day 20 Sprague-Dawley fetuses (Taconic Farms, Germantown, NY) as de- 
scribed (Kass-Eisler et al., 1993).  After enzymatic dissociation, cells were 
pre-plated for 1 h to enrich for myocytes (90-95% of cells after this step). 
Cells were then plated at a density of 700/mm  2 onto 35- or 60-mm tissue 
culture dishes (Primaria, Falcon; Becton Dickinson & Co., Lincoln Park, 
N J) and cultured in media consisting of Hanks' salts plus MEM vitamin 
stock, MEM amino acids, MEM nonessential amino acids, 2  mM L-glu- 
tamine, 0.67 mM glycine, 0.92 mM hypoxanthine (all from GIBCO BRL, 
Gaithersburg, MD), 19.6 mM NaHCO3 (pH 7.1-7.2), penicillin, strepto- 
mycin, and  10%  (vol/vol)  FBS  (Hyclone Laboratories,  Logan, UT)  at 
37°C, 5% CO2. 12 h after plating, cells were washed twice with media be- 
fore the addition of fresh media. 
Adenoviruses 
Mutant  human  type  5  adenoviruses,  derived  from  dl309  (Jones  and 
Schenk, 1979),  which lacks a  functional E3  gene, but is phenotypically 
normal in cultured cells, were used throughout these experiments, dl309/ 
E1B- (kindly provided by Dr. Eileen White, Center for Advanced Bio- 
technology and Medicine, Piscataway, NJ)  contains the wild-type  E1A 
gene, which is transcribed into alternatively spliced 12S and 13S mRNAs 
encoding 243- and 289-residue proteins, respectively, but lacks a  func- 
tional EIB gene. d1520/E1B- and its derivatives (generous gifts from Dr. 
Stanley  T.  Bayley, McMaster  University, Hamilton,  Ontario,  Canada) 
contain an E1A gene in which the 5' splice site needed to generate the 13S 
transcript has been mutated, resulting in the production of only the 12S 
transcript and the 243-amino acid protein; these viruses also lack a func- 
tional EIB gene. Derivatives of d1520EIB- containing additional muta- 
tions in the E1A gene include dlllO1/520EIB- (deletion of residues 14-25), 
dlllO8/520EIB-  (deletion  of  residues  124-127),  and  dlO1/O8/520E1B- 
(with both of these deletions) (Howe et al., 1990).  dl312 lacks functional 
E1 and E3 genes (Jones and Shenk, 1979). Viruses were grown up on 293 
cells, purified on CsCI gradients, and then titered by plaque assay on 293 
cells (Jones and Shenk, 1979). 
Infection 
Ceils were infected 36 h after plating at a multiplicity of infection (MOI) 
of 10 or 20 plaque-forming units (pfu) per cell as specified in a volume of 1 
ml for 60-mm plates and 0.5 ml for 35-mm plates of serum-free media and 
incubated at 37°C, 5% CO2. Plates were gently swirled every 15 min. After 
1.5 h, serum-containing media was added to plates so that the final serum 
concentration was 10%. Infection efficiency of myocyte cultures was de- 
termined by double immunofluorescence for E1A (Ab-1 from Oncogene 
Science [Uniondale, NY]; used at  1:20 dilution) and ventricular myosin 
light chain 2 (MLC2v; lwaki et al., 1990),  which was generously provided 
by Dr. Ken Chien (University of California at San Diego) and used at 1:20 
dilution or desmin (Sigma Chemical Co., St. Louis, MO; used at 1:10 dilu- 
tion). Alternatively, staining was performed with a polyclonal adenoviral 
antibody (gift from Dr. Erik Falck-Pedersen, Cornell University Medical 
College,  New  York;  used at  1:1,000  dilution).  Steady-state E1A  levels 
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amide gels, transferring to nitrocellulose membranes, and immunoblotting 
using the E1A antibody at a  1:200 dilution. Bands were detected by en- 
hanced  chemiluminescence (Amersham Corp.,  Arlington  Heights, IL) 
and quantified by laser densitometry of autoradiograms exposed in the 
linear range (Molecular Dynamics, Sunnyvale, CA). 
5-Bromo-2 " Deoxy- Uridine Incorporation 
Nuclear 5-bromo-2'-deoxy-uridine (BrdU) incorporation and cytoplasmic 
muscle-specific antigens were simultaneously  visualized using double indi- 
rect immunofluorescence. Cultures were pulsed with BrdU (Amersham) 
at a final concentration of 20 p~M for the time period indicated. At the end 
of the pulse, cells on coverslips were fixed in 3.7% (vol/vol) formaldehyde 
for 10 min at room temperature, permeabilized with 70% ethanol for 30 
min at -20°C, and incubated with 10% normal goat serum followed by a 
mouse monoclonal anti-BrdU antibody (undiluted; Amersham) and the 
rabbit  polyclonal  antibody  against  either  MLC2v  or  desmin as  noted 
above. Primary antibodies were then detected with rhodamine-conjugated 
goat anti-mouse IgG  and FITC-conjugated goat anti-rabbit  |gG (both 
used at 1:40; The Jackson Laboratory, Bar Harbor, ME), mounted with 
Flu-mount  (Fisher  Scientific,  Pittsburgh,  PA),  and  examined using an 
MRC 600 confocal microscope (Bio Rad, Hercules, CA) with a Kr/Ar laser. 
Nucleosomal Ladder Assay 
At the times indicated after infection, cells were harvested by scraping 
into the media. After centrifugation at 500 g for 5 min at 4°C, cells were lysed 
in 10 mM Tris, pH 8.0, 5 mM EDTA, 100 mM NaCl, 0.5% (vol/vol) SDS, 
and 1 }xg/ml proteinase K (Sigma Chemical Co.) at 37°C for 5 h on an or- 
bital rocker followed by the dropwise addition of 4 M NaC1 to a final con- 
centration of 1 M and incubation at 4°C overnight (Mymryk et al., 1994). 
After centrifugation at 12,000 g for 30 min at 4°C, the supernatants were 
recovered, extracted with an equal volume of 25:24:1  phenol (Tris-satu- 
rated, pH 8)/chloroform/isoamyl alcohol, and the combination of high mo- 
lecular  weight  and  fragmented  DNAs  were  isopropanol  precipitated, 
washed in 70%  ethanol, resuspended in water, digested with 100  p~g/ml 
RNase A  for 30 min at 37°C, size fractionated on 1.2% agarose gels, and 
stained with ethidium bromide. 
In situ Apoptosis Assay 
48 h after infection, apoptotic cells were identified in situ using the termi- 
nal deoxynucleotidyl transferase UTP nick end labeling (TUNEL) assay 
(Gavrieli et al., 1992).  After fixation in 10% neutral buffered formalin for 
10 min at room temperature and permeabilization in 70% ethanol for 30 
min at -20°C, the TUNEL assay was performed on cells on coverslips us- 
ing the commercially available Fluorescein Apop Tag kit (Oncor, Gaith- 
ersburg, MD) according to the manufacturer's recommendations. In some 
experiments, indirect  immunofluorescence was  simultaneously used to 
identify striated myocytes by staining them with F 59 (Miller et al., 1989), 
a mouse monoclonal antisarcomeric myosin antibody (1:5 dilution; gener- 
ous gift from Dr. Frank Stockdale, Stanford University, Palo Alto, CA), 
followed by rhodamine conjugated goat anti-mouse IgG  (1:40 dilution; 
The Jackson Laboratory). In other experiments, cells were simultaneously 
scored for apoptosis and de novo DNA synthesis by pulsing with BrdU for 
the time period indicated, fixing the cells as for the TUNEL protocol, fol- 
lowed by sequentially performing TUNEL and BrdU staining. 
Results 
E1A Stimulates DNA Synthesis in Cardiac Myocytes 
By embryonic day 20, most cardiac myocytes in the intact 
heart  have withdrawn  from the cell cycle (Rumyantsev, 
1977; Kim et al., 1994). When placed into primary culture, 
only a low percentage of these cells exhibit evidence of on- 
going DNA synthesis even in growth factor-supplemented 
or serum-containing media. To determine whether DNA 
synthesis could be stimulated in this population of cells, 
cultures were infected with dl309/E1B-, a  human type 5 
adenovirus containing a wild-type EIA allele but lacking a 
functional E1B gene. We chose this particular virus to per- 
mit the effects of E1A to be assessed independently of the 
products of the E1B gene, which also interact with host 
proteins involved in cell cycle control. In preliminary stud- 
ies, we confirmed by immunoblot that this virus does in 
fact produce E1A as early as 8 h after infection of cardiac 
myocytes (data not shown). In addition, the efficiency  with 
which d/309/E1B- infects cardiac myocytes at MOI 10 was 
70--80%,  as  determined  by double  immunofluorescence 
for E1A and MLV2v, a striated myocyte specific protein, 
12 h after infection (data not shown). Control plates were 
infected with d/312, which lacks a functional E1A gene, or 
mock infected. Cells were pulsed with BrdU between 24 
and 26 h after infection, after which they were fixed and 
analyzed by indirect  immunofluorescence. Fig.  1  shows 
double staining for BrdU (orange, rhodamine) and MLC2v 
(green, FITC). Mock-infected myocytes (a) and those in- 
fected with d1312 (b) exhibited no evidence of BrdU incor- 
poration by immunofluorescence. In contrast, 70--80%  of 
the  myocytes  in  plates  infected  with  d/309/E1B-  (c) 
showed marked nuclear staining for BrdU. Thus, E1A is 
sufficient to stimulate DNA synthesis in a large proportion 
of cardiac myocytes that do not ordinarily synthesize DNA. 
EIA Induces Apoptosis in Cardiac Myocytes 
To determine whether EiA-stimulated  cardiac myocytes 
go on to mitosis, cells infected with dl309/E1B- or d/312 or 
mock infected, as above, were observed for longer periods 
of time. Beginning 36 h after infection, increasing numbers 
of cells were observed to round up and detach from the 
surface  of the  plates  infected with dl309/E1B-,  but not 
those infected with d/312 or mock infected. By 72 h after 
infection, >70% of the cells on EIA infected plates were 
found floating in the media. Since EIA has been shown to 
induce apoptosis in cycling cells, we wished to determine 
whether cells in the d/309/EiB--infected plates were un- 
dergoing apoptotic death. Therefore, at various times after 
infection, DNA was assayed for nucleosomal laddering, a 
hallmark  of  apoptosis  (Fig.  2).  Only  high  molecular 
weight,  unfragmented DNA  was  recovered from mock- 
and  d/312-infected plates  at  all time points.  In contrast, 
cells infected with d/309/E1B- exhibited nucleosomal lad- 
ders 48 and 72 h  after infection. This experiment shows 
that cell death in EIA-infected plates occurred by apopto- 
sis and that E1A by itself is sufficient to induce this process. 
In rodent hearts, myocytes are  outnumbered ~4:1  by 
nonmyocytes (predominantly fibroblasts). For this reason, 
various strategies to enrich for myocytes are used when 
preparing  primary  myocyte  cultures  from  dissociated 
hearts. Although at the time of plating our cultures typi- 
cally contain 90--95%  myocytes, as judged by staining for 
sarcomeric myosin  (data  not  shown),  there  is  always  a 
small degree of nonmyocyte contamination. Therefore, we 
wished to ascertain whether the apoptosis induced by EIA 
in these  cultures actually occured in myocytes. Cultures 
that  had  been  mock-infected or  infected with  d/312  or 
dl309/E1B- 48 h earlier were fixed and assayed on a cell- 
by-cell basis for the presence of sarcomeric myosin and apop- 
tosis. The TUNEL in situ apoptosis assay is based on the 
increased number of DNA termini in nuclei of apoptotic 
cells,  as  compared with  normal  or necrotic cells.  These 
Liu and Kitsis ElA-induced  DNA Synthesis and Apoptosis in Cardiocytes  327 Figure 1.  E1A-induced DNA synthesis in cardiac myocytes. Primary cultures of embryonic day 20 cardiac myocytes were plated on cov- 
erslips in 6-well dishes. Cells were mock-infected (a) or infected with adenoviruses dl312 (b) or dl309/E1B-  (c) 36 h after plating, pulsed 
with 20 ixM BrdU between 24 and 26 h after infection, fixed, and stained for BrdU (orange, rhodamine) and MLC2v (green, FITC). Du- 
plicate coverslips were examined by confocal microscopy. In plates infected with dl309/EiB-, 70-80% of myocytes were BrdU positive. 
In the field shown in c, six myocyte nuclei were scored as positive. In contrast, in plates infected with d1312 or mock infected, no BrdU- 
positive myocytes were found out of >300 myocytes scored. This experiment was performed using four independent preparations of 
cells with similar results. 
were identified by covalently attaching digoxigenin-tagged 
dUTP to 3' ends with terminal deoxytransferase and sub- 
sequent immunostaining for digoxigenin. As shown in Fig. 
3 c, myosin-positive cells (red, rhodamine) from plates in- 
fected  with  dl309/E1B-  show  clear  evidence  of  nuclear 
staining (green, FITC) indicative of ongoing apoptosis. In 
contrast, no nuclear staining was seen in mock- (Fig. 3 a) or 
dl312-infected  (Fig.  3  b)  plates.  In  addition,  only  occa- 
sional myosin negative cells were found to exhibit nuclear 
staining,  suggesting  that  nonmyocytes  in  these  cultures 
were not as efficiently infected by the virus and/or more 
resistant  to  E1A-induced  apoptosis,  as  compared  with 
Figure 2.  Time  course  of  E1A- 
induced apoptosis in primary cul- 
tures  of  cardiac  myocytes.  Pri- 
mary  cultures  of  embryonic day 
20  cardiac myocytes were  plated 
on  60-mm  dishes  and  mock  in- 
fected (lanes 1-5) or infected with 
adenoviruses dl312 (lanes 6-9) or 
dI309/E1B- (lanes 10-13) 36 h af- 
ter plating. Cells were  harvested 
0-96 h after infection as indicated. 
DNA was  isolated, size fraction- 
ated  on  a  1.2%  agarose  gel, 
stained  with  ethidium  bromide, 
and  visualized  under  ultraviolet 
light.  M,  1-kb  mol  wt  standard. 
This  experiment  was  performed 
using three independent prepara- 
tions of cells with similar results. 
The Journal of Cell Biology,  Volume 133, 1996  328 Figure 3.  E1A-induced apoptosis occurs in cardiac myocytes. Primary cultures  of embryonic day 20 cardiac myocytes were plated on 
coverslips in 6-well dishes and mock-infected (a) or infected with adenoviruses  d/312 (b) or d/309/E1B (c) 36 h after plating. Cells were 
then fixed 48 h after infection, processed for double immunofluorescence  for the TUNEL in situ apoptosis assay (green, FITC) and for 
sarcomeric myosin (red, rhodamine), and duplicate  coverslips were examined by confocal microscopy. This experiment was performed 
using three independent preparations of cells with similar results. 
myocytes. Thus, EIA clearly induces apoptosis in cardiac 
myocytes. 
EIA-induced DNA Synthesis and Apoptosis Occur in 
the Same Cell 
The  experiments  reported  above show  that  E1A  stimu- 
lates both DNA synthesis and apoptosis. These studies do 
not,  however,  address  whether  the  same  cells  undergo 
both processes and, if so, which process occurs first. To ad- 
dress this issue, cells were mock infected or infected with 
dl309/E1B-, pulsed with BrdU starting at 24 h  after infec- 
tion, harvested at 28 or 36 h  after infection, and assayed 
for BrdU incorporation using immunostaining and apop- 
tosis  using  the  TUNEL  assay.  As  demonstrated  previ- 
ously, no BrdU-positive or TUNEL-positive nuclei were 
observed in mock-infected cells at either time point.  Al- 
though ~70%  of nuclei were BrdU positive 28 h  after in- 
fection with dl309/E1B-, no TUNEL-positive nuclei were 
observed at this time (data not shown). The percentages of 
BrdU-positive  and  TUNEL-positive  nuclei  in  cells  har- 
vested  at 36  h  after infection  are  shown  in  Table  I. Al- 
though the total percentage of BrdU-positive nuclei (71%) 
was similar to that observed at the earlier time point, now 
21% of total nuclei were TUNEL positive. Of the BrdU- 
positive nuclei, ,'~30% were also TUNEL positive, examples 
of which  are  shown  in  Fig.  4.  Notably, however, BrdU- 
negative/TUNEL-positive nuclei were not observed. This 
experiment demonstrates that DNA synthesis and apopto- 
sis can occur in the same myocyte and that apoptosis oc- 
curs only in those cells that are or have recently engaged in 
DNA synthesis. Taken together, the progressive increase 
in the number of TUNEL-positive nuclei from 0% at 28 h 
to 21% at 36 h after infection (with ~70% of nuclei BrdU 
positive  at  both  time points)  and  the  absence  of BrdU- 
negative/TUNEL-positive nuclei at either time point sug- 
gest that apoptosis is preceded by DNA synthesis. 
Ability of E1A Mutants to Stimulate DNA Synthesis 
and Apoptosis in Cardiac Myocytes 
The effects of EIA on DNA synthesis and apoptosis in cy- 
cling  cells  are  mediated  by its  interactions  with  cellular 
proteins including  Rb (and related pocket proteins p107 
and  p130)  and  p300  (Howe  et  al.,  1990;  Mymryk et  al., 
1994). To gain insight into whether these same cellular pro- 
teins play a role in the G1/S barrier to cell cycle progres- 
sion in cardiac myocytes, we expressed wild-type and mu- 
tant  E1A  proteins  in  these  cells  using  EIB-  deficient 
adenoviruses, d1520EIB-  was used as the  wild-type con- 
trol  in  these  experiments  because  each  of  the  mutants 
tested was derived from it. In contrast to dl309fE1B- used 
in the previous experiments, which encodes both the 243- 
and  289-  amino  acid  alternative  splice  products  of  the 
E1A gene, d/520EIB- gives rise to only the shorter of the 
proteins. In cycling cells, however, this gene product pos- 
sesses  all  of the  host  cell  DNA  synthetic  and  apoptosis 
functions  of the  longer protein  (reviewed in Bayley and 
Mymryk, 1994). In addition, it binds p300, pRb, p107, and 
p130 normally. Mutant EIA proteins were encoded by de- 
rivatives  of  dI520/E1B-  including:  (a)  dlllOS/520E1B-, 
whose EIA lacks residues 124-127.  Quantitative immuno- 
precipitation studies have demonstrated that this E1A mu- 
tant is completely unable to bind Rb and p130, and that it 
binds only 3% as much p107 as wild-type (Barbeau et al., 
1992). In contrast, p300 binding is near normal. (b) dlllO1/ 
520E1B-,  encoding an E1A protein lacking residues  14- 
25, rendering it completely defective with respect to p300 
binding. In contrast, it retains the ability to bind Rb, p107, 
and p130, although slightly less well than wild-type (Bar- 
beau  et  al.,  1992).  (c)  dlO1/O8/520E1B-,  which  contains 
both of the above mutations. All four dI520EIB- viruses 
were titered on 293 cells to establish the concentrations of 
infective  particles  in  each  stock.  Cultured  cardiac  myo- 
cytes were infected with these viruses, pulsed with BrdU 
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were plated on coverslips in 6-well dishes and mock infected (a-c) or infected with dl309/E1B- (d-f) 36 h later. Cells were then pulsed 
with 20 I~M BrdU 24-36 h after infection, fixed, and processed for double immunofluorescence for BrdU (b and e, rhodamine) and the 
TUNEL in situ apoptosis assay (c and f, FITC). Duplicate coverslips were examined by confocal microscopy, a and d are phase contrast 
views of the corresponding immunofluorescence images. Note the BrdU-positive/TUNEL-positive nuclei in the field shown. In other 
fields, significant numbers of BrdU-positive/TUNEL-negative nuclei were seen, but BrdU-negative/TUNEL-positive nuclei were not ob- 
served (see Table I). 
between  24  and  36  h  after  infection,  and  analyzed  for 
BrdU incorporation and MLC2v expression by double im- 
munofluorescence. 
Fig. 5 A  shows the percentage of myocyte nuclei con- 
taining BrdU. As observed previously, BrdU was not de- 
tectable  by immunofluorescence in  the  nuclei  of mock- 
infected myocytes. On the other hand, 86% (MOI 10) and 
Table L Quantitation  of BrdU and TUNEL-positive  Nuclei 36 h 
after Infection 
Mock infection  dI309/E1B- 
BrdU-/TUNEL-  155  39 
BrdU-fI'UNEL  +  0  0 
BrdU+/TUNEL  -  0  69 
BrdU+/TUNEL  +  0  28 
Total  155  136 
Methods are as described in Fig. 4. 
94% (MO120) of myocyte nuclei were BrdU positive after 
infection with d1520E1B-, confirming that the 243-residue 
E1A protein is  sufficient to stimulate  DNA synthesis in 
cardiac myocytes. At both MOI 10 and 20, the E1A mutant 
defective for pocket protein binding was almost as effec- 
tive as the wild-type protein at stimulating DNA synthesis. 
In contrast, the mutant unable to bind p300 was 4.1- (MOI 
10, P  <  0.001)  to 2.4-fold (MOI 20, P  <  0.005)  less  effi- 
cient. The percentage of myocytes positive for EIA pro- 
tein at 24 h after infection was similar for each of the vi- 
ruses, as was the abundance of EIA protein by immunoblot 
(data not shown). Thus, the decreased ability of the p300 
binding mutant to stimulate DNA synthesis in cardiac myo- 
cytes is attributable to the mutation itself rather than to a 
decrease in the amount of E1A protein per myocyte. 
Infection with  dlO1/O8/520E1B-,  encoding the  mutant 
defective for binding both pocket proteins and p300, re- 
suited in  a very low percentage of BrdU-positive nuclei. 
Although its infection efficiency, as determined by immu- 
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tants  to  stimulate  DNA syn- 
thesis and apoptosis in cardiac 
myocytes. Primary cultures of 
embryonic day 20 cardiac myo- 
cytes  were  mock  infected 
(mock) or infected with aden- 
oviruses encoding various EIA 
proteins: double rout, defective 
for  binding  p300 and  pocket 
proteins;  Ap300, defective for 
p300 binding; zlpocket, defec- 
tive  for pocket  protein  bind- 
ing;  and  12SEIA,  wild-type 
12S E1A. (a) After infection at 
MOI  10  or  20  as  indicated, 
cells were pulsed with 20 I~M 
BrdU 24-28 h after infection, fixed, stained for BrdU and MLC2v, and examined by confocal microscopy. In each experiment, >200 
cells were scored on each of two coverslips for the percentage of MLC2v-positive cells with BrdU-positive nuclei. The results from a 
representative  experiment are presented  as the means --- SE of these counts. This experiment was performed  on three independent 
preparations of cells with similar results. Statistical comparisons: MOI 10, P < 0.001 for 12S E1A vs mock, double mut, and Ap300, and 
for Apocket vs double mut; P < 0.005 for Ap300 vs double mut. MOI 20, P < 0.001 for 12S E1A vs mock and double mut; P < 0.005 for 
12SEIA vs Ap300; and for Apocket vs double mut; P < 0.05 for Ap300  vs double mut. (b) Cells were harvested 48 h postinfection at MOI 
10 and assayed for nucleosomal laddering. M, 1-kb mol wt standard. This experiment was performed on three independent preparations 
of cells with similar results. 
nostaining with a polyclonal adenoviral antibody, was sim- 
ilar to that of d1520E1B-, the double-mutant consistently 
resulted  in  lower  E1A  levels  by immunoblot  (data  not 
shown). In an  attempt to increase the  abundance of the 
doubly  mutated  E1A,  we  infected  dlO1/O8/520E1B-  at 
MOI 20 and compared the resulting E1A levels and per- 
centage of BrdU-positive  myocyte nuclei  with  those  re- 
sulting from infection of d1520E1B- at MOI 10. Infection 
with dlO1/O8/520E1B-  at MOI 20 resulted  in E1A levels 
that  were  55%  of  those  resulting  from  infection  with 
d1520E1B- at MOI 10. In contrast, infection with dlO1/08/ 
520E1B- at MOI 20 resulted in >20-fold fewer BrdU-pos- 
itive  myocyte  nuclei,  as  compared  with  infection  with 
d1520/E1B-  at  MOI  10.  Although  the  possibility  of  a 
threshold  effect cannot be  excluded,  this  result  suggests 
that  simultaneous  mutations  in  residues  required  for 
pocket protein and p300 binding severely limit the ability 
of E1A to stimulate DNA synthesis in cardiac myocytes. 
We  also assessed  the  effect of the  various mutants on 
the ability of E1A to induce apoptosis in cardiac cultures 
by assaying lysates for DNA fragmentation 48 h after in- 
fection at MOI 10 (Fig.  5 B) and 20 (results similar, data 
not shown). The DNA of cells infected with d1520E1B- 
(12S  E1A)  exhibits  marked  nucleosomal laddering  con- 
firming that the 243-residue E1A protein is sufficient to in- 
duce apoptosis.  In contrast,  no detectable  apoptosis was 
seen  in  mock-infected cells  (mock)  or in  those  infected 
with the dlO1/O8/520E1B-  (double rout). Definite nucleo- 
somal laddering was present, however, in lanes containing 
DNA from cells infected with dlllO8/520E1B-  (Apocket) 
and dlllO1/520E1B-  (Ap300).  Thus,  mutants  that  retain 
either pocket protein or p300 binding function are suffi- 
cient to stimulate apoptosis in these cells. 
Discussion 
Most  cultured  cardiac  myocytes  do  not  engage  in  net 
DNA synthesis, even in the presence of serum growth fac- 
tors. E1A stimulates this process in almost all successfully 
transduced myocytes. This  observation suggests that the 
block to DNA synthesis normally present in these cells is 
mediated by the same or similar molecules that gate the 
G1/S transition in cycling cells. Since E1A is thought to in- 
duce DNA synthesis in  cycling cells  through its  interac- 
tions with cellular proteins, it follows that at least some of 
the  proteins involved in  blocking DNA synthesis in car- 
diac myocytes may be targets for E1A binding. 
To gain insight into which cellular proteins may be in- 
volved, we assessed the abilities of various E1A mutants to 
stimulate  DNA synthesis in cardiac myocytes. Mutations 
disrupting  p300  binding  decrease  E1A-stimulated  DNA 
synthesis in cardiac myocytes. This effect is severalfold in 
the context of an E1A molecule that retains the ability to 
bind,  and presumably inactivate, pocket proteins.  In the 
absence of E1A pocket protein binding, the usual situation 
in  the  cell,  loss of p300 binding decreases  the  ability of 
E1A to stimulate DNA synthesis markedly, although we 
are unable to quantitate this effect precisely because of the 
slightly lower levels in the cell of the E1A double mutant. 
While this paper was in review, a study was reported eval- 
uating the effects of an independent set of E1A mutants in 
neonatal cardiac myocytes (Kirshenbaum and Schneider, 
1995).  While the results of the two studies are in general 
agreement, they differ in that the effect of isolated loss of 
p300 binding on DNA synthesis reported herein was not 
observed in  the  other study.  This difference may reflect 
subtle  effects  of the  precise  mutations  used  in  the  two 
studies or differences between fetal and neonatal cardiac 
myocytes. Regardless, both studies demonstrate that resi- 
dues required for p300 binding play an important role in 
the ability of E1A to stimulate DNA synthesis in cardiac 
myocytes. 
The most straightforward interpretation  of this data is 
that p300 or a p300-1ike protein exists in cardiac myocytes 
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utes to the inhibition of cellular DNA synthesis. We has- 
ten to emphasize, however, that since the identities and 
functions of proteins in cardiac myocytes that interact with 
E1A residues required for p300 binding have not yet been 
determined, this interpretation must be regarded as condi- 
tional. In addition, this model assumes that the absence of 
DNA synthesis in cardiac myocytes results from active re- 
pression rather than simply being the default mode. This 
view is  supported  by skeletal myoblast/myocyte hetero- 
karyon experiments demonstrating dominance of the phe- 
notype characterized by the absence of net DNA synthesis 
(Clegg and Hauschka, 1987). It remains to be determined 
whether this is also the case in cardiac myocytes in light of 
experiments demonstrating the lack of dominance of car- 
diac gene expression in fusions between cardiac myocytes 
and fibroblasts (Evans et al., 1994). 
p300  is  the prototype member of a  family of bromo- 
domain-containing transcriptional adaptor molecules that 
are thought to transactivate the expression of target genes 
by interacting simultaneously with specific enhancer bind- 
ing proteins and components of the basal transcriptional 
apparatus (Eckner et al.,  1994; discussed in Arany et al., 
1994). Members of the p300 family appear to be expressed 
ubiquitously. How then can the presence of p300 family 
members  in  cycling as  well  as  terminally differentiated 
cells be reconciled with the possibility that these proteins 
play an important role in excluding the latter from the cell 
cycle? One possibility is that different p300 family mem- 
bers exist in proliferating and postmitotic cells. Another is 
that the activity of the same p300 family member is differ- 
entially modulated in these cells by changes in abundance, 
posttranslational modifications, or interactions with other 
proteins.  The  answers  to  these  questions  will  become 
clearer  as  the  different p300  family members  and  their 
modes of regulation become better defined. 
If the role postulated above for p300 in cardiac myo- 
cytes is correct, one pathway by which it might act to in- 
hibit DNA synthesis is suggested by recent work in termi- 
nally differentiating keratinocytes, demonstrating that it 
plays a role in activating the promoter of the gene encod- 
ing  p21 clP1/wAFt  (Missero  et  al.,  1995).  This  protein,  in 
turn, is a member of the family of universal cyclin-depen- 
dent kinase inhibitors and blocks DNA synthesis and cell 
cycle progression (reviewed in Sherr, 1994). Interestingly, 
p21CIP1/wAFI is also induced during differentiation of C2C12 
myotubes (Halevy et al., 1995; Parker et al., 1995; Missero 
et al., 1995). 
It is well established that Rb plays an important role in 
regulating the G1/S transition in mammalian cells, as well 
as in the terminal differentiation of skeletal myocytes (Gu 
et al., 1993; Schneider et al., 1994),  neurons (Lee et al., 
t994), and lens fiber cells (Pan and Griep, 1994; Morgen- 
besser et al., 1994; and Fromm et al., 1994). Although its 
presence in wild-type cardiac myocytes has not been for- 
mally documented, it is present in extracts of whole-heart 
tissue and in cardiac myocytes that express an SV-40 T an- 
tigen transgene (Kim et al., 1994). Therefore, it was some- 
what surprising that the EIA mutant that is completely de- 
fective for Rb and p130 binding and binds p107 only 3% as 
well as the wild-type protein (Barbeau et al., 1992) retains 
the ability to stimulate DNA synthesis in cardiac myocytes 
almost as efficiently as the wild type. One possible expla- 
nation for this observation is that the expression of E1A 
leads  to  the  inactivation  of  Rb  through  an  alternative 
mechanism. In support of this, E1A has been  shown in 
other cells to induce the phosphorylation of Rb through a 
mechanism independent of its ability to bind this pocket 
protein (Wang et al., 1991). 
As in cycling cells containing functional p53, the end re- 
sult of E1A overexpression in cardiac myocytes is apopto- 
sis. Direct evidence that both processes occur in the same 
cells is shown in Fig. 4. In addition, the data demonstrate 
that: (a) while ~70% of nuclei are BrdU positive both 28 
and 36 h after infection, the number of TUNEL-positive 
nuclei increases from 0 to 21% during the same period of 
time; and (b) while many BrdU-positive nuclei are TUNEL- 
negative 36 h  after infection, all TUNEL-positive nuclei 
are BrdU positive (Table I). Taken together, these find- 
ings suggest that DNA synthesis precedes apoptosis. 
Although tight associations between forced DNA syn- 
thesis and apoptosis have been  observed in the present 
study and previously (Wu  and Levine, 1994; Qin et al., 
1994; Shan and Lee, 1994; Morgenbesser et al.,  1994),  a 
cause and effect relationship between these two processes 
has not been demonstrated. Alternatively, the temporal 
association  between  these  two  processes  could  reflect 
shared proximal signaling events (discussed in Evan et al., 
1995). Conversely, it is clear that a block to DNA synthesis 
is not required for E1A-induced apoptosis because E1A 
elicits apoptosis in cycling cells as well as in those which do 
not ordinarily engage in DNA synthesis. Thus, while in 
some situations apoptosis may represent the resolution of 
conflicting positive and negative growth signals, this does 
not appear  to be  the case with E1A-induced apoptosis. 
Moreover, the outlines of a  plausible scenario by which 
E1A could induce apoptosis have emerged from known 
epistatic relationships: E1A increases steady-state levels of 
p53 through transcriptional (Braithwaite et al.,  1990) and 
posttranscriptional mechanisms (Lowe et al., 1993). p53, in 
turn, is known to activate the expression of the bax gene 
(Miyashita and Reed, 1995), whose product can promote 
apoptosis (Oltvai et al.,  1993). Further work is needed to 
determine whether these events constitute the actual sig- 
naling pathway mediating E1A-induced apoptosis. 
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